Industries › Healthcare Providers
The questions healthcare providers actually ask, answered against the numbers that decide them — with unedited excerpts from real analyses.
The bind specific to this industry is that downside risk has been accepted on 38,000 lives without the cost-per-episode data needed to price it. Almost every strategic question in healthcare providers runs into it eventually, which is why answers borrowed from other sectors tend to point at the wrong lever first.
The numbers that carry most decisions here are cost per episode, payer mix, panel size, contribution per provider. Analysis that starts from revenue and works down rarely reaches them; analysis that starts from them usually settles the question in one pass.
This is unedited output from a completed run on Cedar Ridge Health Partners — 38,000 attributed lives under value-based contracts — a sample profile used for testing rather than a customer.
The subject is Cedar Ridge Health Partners, a sample company profile used for testing rather than a customer — 38,000 attributed lives under value-based contracts.
Excerpt from a real Percision run · Quick Market Scan · sample company profile
The move. Protect and grow the 34% operating-income ASC engine by replacing retiring surgeons and steering 212k attributed lives to the ASC within 24 months.
| Investment required | $3.0-4.0M total over 24 months ($1.8-2.2M surgeon succession + retention bonuses; $1.2-1.8M referral-optimization platform and analytics) |
| Expected return | Incremental $4.8-6.4M annual ASC contribution margin by Month 24; payback 14-18 months on $3.0-4.0M investment; lifts group operating margin from 4.2% to 5.8-6.4%. |
| Revenue, year 1 | $202-208M (ASC case volume +4-6%) |
| Revenue, year 2 | $212-220M (ASC case volume +6-8%; physician retention +2-3%) |
| Revenue, year 3 | $225-235M (ASC contribution ≥40% of operating income) |
| Exit criteria | Strategy abandoned if, by Month 12, fewer than two qualified orthopaedic surgeon candidates have signed LOIs OR if ASC case volume has not grown at least 2% YoY; in either case, board must decide within 30 days whether to pivot to hospital-system sale process at 8-10× EBITDA. |
This is one move out of a full analysis. Read a complete report — every page, no email required.
The engine runs the same structured method on any business, and what changes by industry is which numbers it asks for and which framework it routes to. For healthcare providers that means cost per episode, payer mix, panel size rather than generic benchmarks. Every page in this section carries an excerpt from a completed run so you can judge the depth before spending anything.
Between seven and fifteen minutes for the run itself. You watch it being built, and you see the full output before there is any payment.
It states its assumptions where your data stops rather than refusing to proceed, and it marks which conclusions depend on them. That is more useful than waiting for a dataset you may never assemble.
Describe the situation in your own words and we will tell you which analysis answers it — before you sign up for anything.
Describe my situation →Prefer to skip ahead? Go straight to the free diagnostic.